Next Article in Journal
Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
Next Article in Special Issue
Delivery of Cancer Therapeutics Using Nanotechnology
Previous Article in Journal
Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis
Previous Article in Special Issue
From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)
Article Menu

Export Article

Pharmaceutics 2013, 5(2), 246-260; doi:10.3390/pharmaceutics5020246
Open AccessArticle

Notes on Article Versions

Action Date Notes Link
article pdf uploaded. 23 April 2013 11:49 CEST Version of Record
article html file updated 17 June 2015 08:40 CEST Original file
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top